From Zero to Code: Why This Healthcare Investor Decided to Build a SaaS Platform with AI
When I first encountered ChatGPT-3, I experienced something I hadn’t felt since the early days of genomics or the first iPhone launch – that visceral recognition that everything was about to change. At 60-something, with a career spanning from building companies to investing in them, from writing books about healthcare’s future to advising startups on their journey, I decided to dive headfirst into the deep end of AI-assisted software development. Interestingly, some of the most brilliant people I knew kept insisting this was just a “stochastic parrot” prone to mistakes and hallucinations. They couldn’t have been more wrong in so many ways.
The journey started with constant consumption – reading everything, experimenting with every tool, pushing boundaries to understand what these technologies could really do. My focus has always been healthcare and life sciences, where I’ve lived through multiple technology revolutions. But this felt different. The implications were profound. Everyone kept saying “you can code now” with AI assistance, and I thought, why not test that theory? Not with some trivial exercise or tutorial project, but with something real – a full-scale business application that would take serious time and energy to build.
After careful consideration, I chose to build a comprehensive social media management and SEO platform. You might wonder why I didn’t tackle a healthcare application, given my background writing about predictive analytics in medicine and advising digital health companies. The answer is pragmatic – healthcare applications come loaded with regulatory requirements, HIPAA compliance, integration challenges, and other complexities that would obscure what I was trying to prove. My goal was simple: could I build something genuinely complex and make it work? If I could do that, then tackling healthcare and life sciences applications would be the logical next step.
I started with Lovable, an AI-powered development platform, armed with an ambitious prompt that would make any real developer cringe. But that’s the point – I don’t know the first thing about actual coding. What I do know, from years of building and investing in companies, is that you never accept that something can’t be done. You find a way to get it across the finish line. So when the initial version came together and actually worked, my immediate thought wasn’t satisfaction – it was “if I can do this, why not make it the best it can be?”
This led to an intense period of iteration. I had competitive analysis running with deep research, transforming market insights into feature requirements. Each new capability I wanted to add became an exercise in creative problem-solving. When Lovable showed its limitations, I turned to ChatGPT with requests like “write me the code for this feature, but format it so I can feed it to Lovable.” The AI became my coding partner, translator, and technical advisor all rolled into one.
The platform evolved rapidly. It now features GPT-5 powered content generation with tone-of-voice analysis and brand consistency checks. There’s an autopilot scheduler that predicts optimal posting times based on audience engagement patterns, with each piece of content showing predicted engagement metrics. The template system includes pre-built frameworks for product announcements, educational content, customer success stories, and motivational posts. I even built in A/B testing capabilities, conversion tracking APIs, and competitor analysis tools.
Of course, I broke things – multiple times. Security became an ongoing challenge that required constant attention. There were moments when ambitious “improvements” sent me scrambling back to earlier versions. But each failure taught me something about the development process, about the architecture of modern applications, and about the genuine complexity of what today’s founders are building.
This experiment matters for healthcare innovation in ways that might not be immediately obvious. Throughout my career – from helping build precision medicine companies to hosting a podcast about healthcare’s future – I’ve seen how domain expertise alone isn’t enough. You need to understand the tools and technologies that make transformation possible. As someone who’s written about how AI and predictive analytics are reshaping medicine, I realized I needed to understand not just the theory but the practical reality of building with these technologies.
Consider the implications: if someone with no coding background can build a feature-rich SaaS platform with AI assistance, what could a cardiologist create to solve workflow inefficiencies they face daily? What could a patient with a rare disease build to connect and support their community? What could a researcher develop to accelerate their work without waiting months for IT resources? The democratization of software development isn’t just changing who can build – it’s changing what gets built and how quickly problems get solved.
From an investment perspective, this experience has fundamentally changed how I evaluate opportunities. When founders pitch their AI-powered solutions, I can now dig deeper into their implementation strategies, their approach to prompt engineering, their understanding of the security implications. I can better assess whether they’re genuinely leveraging AI’s transformative potential or simply riding the hype wave. More importantly, I can add value beyond capital – understanding their technical challenges, helping them think through architectural decisions, and connecting them with resources that actually matter.
The platform I built – SparkFlow – includes features like hashtag trend analysis, content optimization engines, ROI tracking, team collaboration tools with role-based permissions, and even privacy-safe conversion tracking through server-side APIs. Is it production-ready? Probably not. There are scalability issues, edge cases I haven’t considered, and security improvements needed. But that wasn’t the point.
The point was to prove that the barrier between expertise and execution has fundamentally shifted. In healthcare, we’re sitting on enormous reservoirs of clinical knowledge, patient insights, and unmet needs. What’s been missing is the ability to rapidly translate these insights into working solutions. AI-assisted development changes that equation entirely. We’re entering an era where the best person to build a clinical decision support tool might be the clinician using it daily, where patients become active participants in creating their care solutions, where researchers can prototype and test hypotheses through custom-built tools.
For those of you who’ve read to the end – one important clarification: this wasn’t a full-time effort. I built this while maintaining all my other workstreams simultaneously. The ability to context-switch between board meetings, investment evaluations, and debugging my platform became part of the learning experience itself. Perhaps I’ll write about productivity and time management in another post, but the key insight is that AI assistance doesn’t just lower the technical barrier – it dramatically reduces the time investment required to build something meaningful.
This isn’t about everyone becoming a software engineer – it’s about domain experts gaining the ability to manifest their ideas into functional reality. It’s about investors understanding what they’re investing in at a deeper level. It’s about accelerating the pace of innovation in fields like healthcare where every inefficiency has human cost and every improvement can save lives.
Looking at what I built – a platform with advanced analytics, AI-powered content generation, automated optimization, and enterprise-grade features – I see more than a social media tool. I see validation that we’re at an inflection point. The same technologies that let me build SparkFlow will enable clinicians to create diagnostic aids, researchers to build analysis platforms, and patients to develop support tools. The question isn’t whether you should learn to “code” with AI assistance. The question is whether you’re ready to embrace a world where your expertise, combined with these tools, can transform ideas into reality in weeks rather than years. In healthcare, where the stakes couldn’t be higher, can we afford not to embrace this change?
